Source: Annual Congress 2013 –The dark side of the moon: when, why, and where I should not use NIV?
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M.W. Elliott (Leeds, United Kingdom). Enough is enough: misuse of NIV in the treatment of chronic patients with exacerbation of symptoms?. Annual Congress 2013 –The dark side of the moon: when, why, and where I should not use NIV?

Member's Comments

No comment yet.

Related content which might interest you: The rationality of the use of NIV in elderly patients with acute COPD exacerbation Source: International Congress 2018 – Non-invasive ventilation for acute respiratory failure Year: 2018 Clinical effectiveness of antidepressive drug in patients with COPD and concomitant moderate depressive episode Source: Annual Congress 2013 –COPD treatment and others Year: 2013 Exacerbation types by COPD severity; risk of hospitalisation by patients not seeking treatment Source: Eur Respir J 2003; 22: Suppl. 45, 353s Year: 2003 Under reporting acute exacerbation in patient with COPD: incidence and predictors? Source: Eur Respir J 2006; 28: Suppl. 50, 175s Year: 2006 Do patients with recurrent exacerbations of COPD requiring NIV receive higher pressures than those that are NIV naive? Source: Annual Congress 2013 –New evidence for NIV in the acute setting Year: 2013 Withdrawal of inhaled corticosteroids in people with chronic obstructive pulmonary disease (COPD) in primary care – a randomised controlled trial Source: Annual Congress 2005 - Effects of anti-inflammatory drugs on COPD Year: 2005 Opioid prescription for severe chronic breathlessness to hospitalised patients with COPD - a clinical audit Source: Virtual Congress 2020 – Clinical data and COPD management Year: 2020 Factors associated with relapse after ambulatory treatment of acute exacerbations of chronic bronchitis Source: Eur Respir J 2001; 17: 928-933 Year: 2001 Characteristics and medication use of the patients with acute exacerbations of asthma-COPD overlap syndrome Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage? Year: 2015 Difficulty in management of COPD exacerbation: Is this chronic exacerbation or difficult COPD: “A specific phenotype?” Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Polypharmacy in patients with acute exacerbation of COPD Source: Annual Congress 2011 - COPD management Year: 2011 The diagnosis and treatment of chronic cough patients Source: Eur Respir J 2005; 26: Suppl. 49, 300s Year: 2005 Effect of exacerbation history and ICS use on outcomes in COPD patients from the TIOSPIR™ trial Source: International Congress 2015 – New data on established treatments for COPD Year: 2015 Physiological impairments and exacerbation risk in COPD patients with less symptom and no frequent exacerbation history. Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD Year: 2021 Can we use a biomarker to guide antibiotic treatment in severe COPD exacerbations? Source: Breathe, 15 (4) 353; 10.1183/20734735.0257-2019 Year: 2019 Peculiar properties of sleep structure and impact of antidepressive therapy in COPD patients with concomitant depressive episode Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Life-sustaining treatment preferences of patients with severe COPD Source: Annual Congress 2010 - Pulmonary rehabilitation and chronic care: new developments in interventions, assessment and care Year: 2010 Which are the factors and causes that lead to omalizumab withdrawal in severe asthma patients? Source: International Congress 2018 – New developments in the treatment of asthma Year: 2018 Can we personalize COPD treatment by exacerbation frequency and severity? Three years of follow-up Source: International Congress 2016 – In-patient and out-patient COPD management Year: 2016 Is CRP-guided antibiotic treatment a safe way to reduce antibiotic use in severe hospitalised patients with exacerbations of COPD? Source: Eur Respir J, 54 (4) 1901405; 10.1183/13993003.01405-2019 Year: 2019